Correction to: HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8+ T and NK cells: a novel therapeutic tumour vaccine.

ABSTRACT:

SUBMITTER: Yu Z 

PROVIDER: S-EPMC8482666 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature